Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K administration route after excessive warfarin anticoagulation
ChiCTR1900023759Phase 4Not yet recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phytomenadione in warfarin-induced coagulopathy (4 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Adverse event. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
phytomenadione
03
Conditions
warfarin-induced coagulopathy
Beyond the preview
Go deeper on ChiCTR1900023759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023759.